drugset / Trial / NCT00327197
Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate and compare the expression and change in expression of key severe asthma targets at baseline in mile to moderate asthmatics vs. severe asthmatic subjects. To evaluate and compare the airway pathology at baseline and changes in airway pathology in relation to asthma severity.
Timeline
- Start
- 2005-08-02
- Primary completion
- 2011-06-06
- Completion
- 2011-06-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisolone | Other / unclassified | 0.5 mg/kg | Oral |